POSTPONED: Residential Course - Clinical Oncology: H&N Cancers, Uveal Melanoma, Rare Skin Cancers

Due to the ongoing Coronavirus (COVID-19) crisis we have made the decision to postpone the Residential Course - Clinical Oncology: Head and Neck Cancers, Uveal Melanoma, Rare Skin Cancers. We will be in contact with more details about this as soon as they are confirmed.

We deeply regret having to take this decision but we feel that in the current climate we all need to do our part in trying to limit the diffusion of the virus as much as possible and this was the only decision possible considering your role in society as medical staff.

We apologize for any inconvenience caused but we think you’ll all agree that this solution was unavoidable.

Scientific Coordinator: L. Licitra, IT


This residential course on head and neck cancers is aimed at an international audience of clinical oncologists interested in advancing their knowledge and skills in the clinical management of these tumors, within a multidisciplinary context.
“Networking” is the key to improving the quality of care for rare cancers, therefore the course is developed in the framework of EURACAN, the European Reference Network on rare adult solid cancers, with the aim of reinforcing the collaboration among oncologists from different countries who are already part of the network or willing to join in the near future.

LEARNING OBJECTIVES
- To provide an overview of current multidisciplinary state-of-the-art treatment of head and neck cancers
- To discuss relevant clinical cases on a multidisciplinary basis
- To establish connections for future distance clinical mentoring/tutoring/networking

The residential course on head and neck cancers is an ESO - EURACAN joint initiative
Held in collaboration with

INVITED FACULTY
S. Alfieri, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
M. Angi, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
P. Bossi, Medical Oncology, University of Brescia, IT
P.G. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
S. Cavalieri, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
M.R. Fiore, CNAO Foudation, Pavia, IT
G. Gatta, Fondazione IRCCS Istituto Nazionale Tumori, Milano IT
F. Huguet, Hopital Tenon, Paris FR
A. Iacovelli, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
L. Licitra, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
L. Locati, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
P. Morbini, Department of Pathology, University of Pavia, IT
E. Orlandi, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
C. Piazza, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
L. Preda, Istituto Europeo di Oncologia, Milano, IT
A. Schindler, Department of Clinical and Biomedical Sciences, University of Milan, IT
C. Simon, Université de Lausanne, CHUV Lausanne, CH
B. Vischioni, CNAO Foudation, Pavia, IT
A. Trama, Fondazione IRCCS Istituto Nazionale Tumori, Milano IT

ORGANISING SECRETARIAT
European School of Oncology
Rare Tumours Programme
Marina Fregonese
email: mfregonese@eso.net
phone: +39 02 23902106

ACCREDITATION
Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME).
EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the application can be obtained from the organising secretariat.

OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.

VENUE
The course will be held on 6 and 7 July, 2020 at

Fondazione IRCCS Istituto Nazionale Tumori
Room G
Via G. Venezian 1
Milan, IT



The third day of the course (July 8) will be held at CNAO Foundation - Strada Campeggi, 53 - Pavia.
Transfer from Istituto Nazionale Tumori to CNAO will be organized. Information about the transfer will be given during the course.

PARTICIPANT'S PROFILE
• Medical degree
• Current involvement in clinical activities in oncology
• Fluency in English

Priority will be given to younger candidates and low/middle income countries.
Only applications with all required information and attachments will be considered.

THE ONLINE APPLICATION SYSTEM WILL OPEN SOON

6 July

 7 July

 8 July